Does CAPTOPRIL Cause Nephrocalcinosis? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Nephrocalcinosis have been filed in association with CAPTOPRIL (Captopril). This represents 0.4% of all adverse event reports for CAPTOPRIL.
5
Reports of Nephrocalcinosis with CAPTOPRIL
0.4%
of all CAPTOPRIL reports
0
Deaths
4
Hospitalizations
How Dangerous Is Nephrocalcinosis From CAPTOPRIL?
Of the 5 reports, 4 (80.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Nephrocalcinosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPTOPRIL. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does CAPTOPRIL Cause?
Drug ineffective (122)
Hypotension (97)
Hypertension (96)
Nausea (86)
Condition aggravated (85)
Dyspnoea (78)
Drug hypersensitivity (70)
Diarrhoea (68)
Acute kidney injury (62)
Asthenia (57)
What Other Drugs Cause Nephrocalcinosis?
FUROSEMIDE (111)
CALCIUM (65)
CALCITRIOL (64)
LANSOPRAZOLE (51)
OMEPRAZOLE (49)
ASFOTASE ALFA (45)
PANTOPRAZOLE (41)
PREDNISOLONE (39)
SODIUM, DIBASIC\SODIUM, MONOBASIC (32)
DENOSUMAB (31)
Which CAPTOPRIL Alternatives Have Lower Nephrocalcinosis Risk?
CAPTOPRIL vs CARBAMAZEPINE
CAPTOPRIL vs CARBETOCIN
CAPTOPRIL vs CARBIDOPA
CAPTOPRIL vs CARBIDOPA\ENTACAPONE\LEVODOPA
CAPTOPRIL vs CARBIDOPA\LEVODOPA